Moody’s raises its ratings on FCA N.V.
Moody’s Investors Service communicated yesterday that it has upgraded from “Ba1” to “Baa3” the Issuer Rating of FCA N.V. (NYSE: FCAU / MTA: FCA), and from “Ba2” to “Baa3” the rating on the bonds issued or guaranteed by FCA N.V..
The short-term rating is upgraded from “(P) NP” to “(P) P-3”.
The outlook on all ratings is stable.
London, 12 January 2021
Attachment
Just two years ago, who would have thought that dishwashers could become an intrinsic part of Indian city-life?
The poet, a source of inspiration to the founders of Liberalism and Socialism, penned more than 550 verses and songs before he died at 37
Tiger King star is said to be more hopeful of his chances now Trump is gone
The "US Software Defined Data Center Market Forecast to 2027 - COVID-19 Impact and Country Analysis by Component and Industry Vertical" report has been added to ResearchAndMarkets.com's offering.
The "Global Headphones Market 2021-2025" report has been added to ResearchAndMarkets.com's offering.
The Chelsea hierarchy have lost faith in the club legend
Having played Princess Diana, the actress wants to break away from playing "posh English" women
Sales of the Bridgerton novels, by American writer Julia Quinn, have exploded in the wake of the hit Netflix series.
The death toll from storm Eloise rose to at least 12 on Monday, according to figures from authorities across south-eastern Africa, where heavy winds, rain and flooding have also destroyed buildings and crops. A tropical cyclone when it made landfall at Mozambique's central province of Sofala on Saturday, Eloise subsequently weakened to a tropical storm as it moved inland to dump rain on Zimbabwe, eSwatini - formerly known as Swaziland - South Africa and Botswana. Six people were killed in Mozambique, the country's National Institute for Disaster Risk Management and Reduction (INGD) reported, while the number of displaced people rose to more than 8,000.
The "Europe Telecom Billing and Revenue Management Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Type (Telecom Billing, Cloud Billing, and IoT Billing); Component (Solution and Services); Deployment Type (Cloud, On-premise, and Hybrid); and Country" report has been added to ResearchAndMarkets.com's offering.
To Nasdaq Copenhagen A/S 25 January 2021 Nykredit Realkredit A/S - Extraordinary general meeting 2021 The following proposals were adopted at Nykredit Realkredit’s extraordinary general meeting on 25 January: The board of directors’ proposal to implement a merger of Nykredit Realkredit A/S and LR Realkredit A/S in accordance with the merger plan of 11 December 2020 with Nykredit Realkredit A/S as the surviving company and LR Realkredit A/S as the non-surviving company was adopted; see below.The board of directors’ proposal to take over all of LR Realkredit A/S' secondary names was adopted and article 1(2) of the Articles of Association was amended to reflect this resolution.The board of directors’ proposal to take over LR Realkredit A/S’ fund reserve on unchanged terms was adopted and a new article 29(2) was inserted in the articles of association to reflect this resolution.The chair of the meeting was authorised – with the power of delegation and substitution – to register the adopted resolutions with the Danish Business Authority and the Danish Financial Supervisory Authority. The merger of Nykredit Realkredit A/S and LR Realkredit A/S is completed with effect as of the date on which all the conditions for the merger have been fulfilled. At the same time, the legal effects of the merger will enter into force in pursuant to section 250 of the Danish Companies Act. The Minister for Industry, Business and Financial Affairs approved the merger on 18 January 2021 pursuant to section 204 of the Danish Financial Business Act. The completion of the merger is thus solely conditional upon (i) the merger being adopted at the general meeting of LR Realkredit A/S, and (ii) the merger being registered with the Danish Business Authority. The adoption of the merger at LR Realkredit A/S’ general meeting and the registration of the merger with the Danish Business Authority are expected to take place today, 25 January 2021. Nykredit Realkredit A/S will publish a separate company announcement, once the conditions are fulfilled and the merger has been completed. Further information: Questions may be addressed to Nykredit Press Relations, tel +45 44 55 14 83. Attachment Extraordinary general meeting 2021 - Nykredit Realkredit - 25012021
Airline calls ASA ruling ‘baseless’ but says it will comply
President Joe Biden will take steps on Monday to harness the purchasing power of the United States government, the world's biggest single buyer, to increase domestic manufacturing and create markets for new technologies, a senior administration official said. Increasing U.S. manufacturing, a central tenet of Biden's presidential campaign, has proven a vexing challenge for previous administrations, including that of former President Donald Trump https://www.reuters.com/article/us-usa-trump-steel/trump-buy-american-edict-may-have-little-impact-on-u-s-steel-idUSKBN17K2OE.
Manchester [UK], January 25 (ANI): Liverpool manager Jurgen Klopp has said that he will get his forwards (Mohamed Salah, Sadio Mane, Robert Firmino) firing on all cylinders in the upcoming matches.
A prosecutor said the manslaughter plea was acceptable to the Crown.
The "Western Europe: Brewing Waste Market and the Impact of COVID-19 in the Medium Term" report has been added to ResearchAndMarkets.com's offering.
Dublin, Jan. 25, 2021 (GLOBE NEWSWIRE) -- The "Respiratory Infection Diagnostic Markets by Technology, Plex, Place and by Region with COVID-19 Impact & Forecasting/Analysis, and Executive and Consultant Guides 2021-2025" report has been added to ResearchAndMarkets.com's offering. The Multiplex factor is creating market confusion while lowering costs and improving care but important factors are holding back progress. COVID-19 has broken open the market for point of care testing of respiratory infections. Now the competition for market share begins in earnest. Large new markets are opening up. In health facilities, clinics, physicians' offices and elsewhere. And let's not forget the screening market, not just for COVID, but for the rest of the 20 something respiratory pathogens as well. Multiplex vs single plex? Explore the rapidly changing market as competitors jockey for position in new markets that are not yet well understood. New technology is forever changing the diagnosis of respiratory infections. Shrinking time to result is opening up markets multiple times the size of current microbiology based practice. Diagnosis has already moved into the Emergency Room. It is now moving to the Physician's Office Lab. Could the Home be next? The widespread nature of respiratory infections, (young people can get 8 colds a year) means that potential market sizes are enormous. Respiratory, already the largest infectious disease category could multiply in size. This is a growth opportunity for all diagnostic companies. Understand the opportunity and the risk with this in-depth report. Key Topics Covered: Respiratory Infections Diagnostic Market - Strategic Situation Analysis and Impact of COVID-19 Guide for Executives, Marketing, Sales and Business Development StaffGuide for Management Consultants and Investment Advisors 1. Introduction and Market Definition 2. Market Overview 2.1 Players in a Dynamic Market 2.1.1 Academic Research Lab 2.1.2 Diagnostic Test Developer2.1.3 Instrumentation Supplier 2.1.4 Distributor and Reagent Supplier 2.1.5 Independent Testing Lab2.1.6 Public National/regional lab 2.1.7 Hospital lab 2.1.8 Physician Office Labs 2.1.9 Audit Body 2.1.10 Certification Body2.2 Respiratory Infections 2.2.1 Upper vs. Lower - Marketing Implications2.2.2 Understanding the Role of Pneumonia 2.2.3 Bacterial Infections2.2.4 Tuberculosis - A Special Case 2.2.5 Viral Infections 2.2.6 Fungal and Other Pathogens 2.3 Diagnostics - A Changing Role 2.3.1 Historical Practice2.3.2 Current Diagnostics 2.3.3 The Multiplex Vector 2.3.4 Future Diagnostics - The Question of When and Where 2.3.5 Respiratory Infection Diagnostics - The Destination 2.3.6 Diagnostics as Defensive Weapons 2.4 COVID-19 2.4.1 Signs and symptoms 2.4.2 Transmission2.4.3 Diagnosis 2.4.4 Prevention 2.4.5 Management 2.4.6 Prognosis 2.5 Pandemic Diagnostics 2.5.1 Risk Management - Spark and Spread 2.5.2 Dx Technology - Nucleic Acid Based2.5.3 Dx Technology - Immunoassay & Serology 2.5.4 Time to Market and Preparedness Issues 2.5.5 Unrecognized Role of Multiplex in Pandemic Management 3. Market Trends3.1 Factors Driving Growth 3.1.1 Syndromic Multiplexing 3.1.2 T.A.T3.1.3 Antimicrobial Resistance Movement3.1.4 Pandemic Mitigation 3.1.5 An Aging at Risk Population 3.2 Factors Limiting Growth3.2.1 The Cost Curve 3.2.2 Regulation and coverage 3.2.3 Laissez Faire 3.3 Instrumentation and Automation3.3.1 The Shrinking Multiplexing Machine 3.3.2 Bioinformatics Networking and Anonymous Reporting 3.4 Diagnostic Technology Development3.4.1 The Key Role of Time to Result 3.4.2 Single Cell Genomics Changes the Picture 3.4.3 Pharmacogenomics Blurs Diagnosis and Treatment 3.4.4 Pathogen Identification - A Projected Timetable of the Future 4. Respiratory Infection Diagnostics Recent Developments 4.1 Recent Developments - Importance and How to Use This Section 4.1.1 Importance of These Developments 4.1.2 How to Use This Section 5. Profiles of Key Players Abacus DiagnosticaAbbott DiagnosticsAccelerate DiagnosticsAdor DiagnosticsAkkoni BiosystemsAlveo TechnologiesApplied BioCodeAtlas GeneticsAus DiagnosticsBD DiagnosticsBiocartisBioFire DiagnosticsbioMerieuxBio-Rad LaboratoriesBosch Healthcare Solutions GmbHCepheidCo-DiagnosticsCue HealthCuretisDiagenode DiagnosticsDiascopicDiasorinExpedeonFusion GenomicsGenePOC DiagnosticsGenetic SignaturesGenMark DxHologicImmunexpressInflammatixInvetechJanssen DiagnosticsKariusLexigeneLuminexLumos DiagnosticsMammoth BiosciencesMbio DiagnosticsMeridian BioscienceMesa BiotechMobidiagNanomixOxford NanoporePanagenePrimerdesignProminexQiagen (Statdx)QuantumdxQuidelRoche Molecular DiagnosticsSaw DiagnosticsSeegeneSensovationSiemens Healthineers (Fast Track Diagnostics)SkylineDxSona NanotechT2 BiosystemsThermo FisherVeradus LabsVeramarx 6. The Global Market for Respiratory Infection Diagnostics 6.1 Global Market Overview by Country6.2 Global Market by Technology - Overview 6.3 Global Market by Plex - Overview 6.4 Global Market by Place - Overview 7. Global Respiratory Infection Diagnostic Markets - By Technology 7.1 Microbiology 7.2 PCR 7.3 NGS7.4 Immunoassay/Other7.5 C19 Singleplex 8. Global Respiratory Infection Diagnostic Markets - by Plex 8.1 C19 Single Plex8.2 Singleplex 8.3 Duplex/Triplex 8.4 Multiplex Technology 9. Global Respiratory Infection Diagnostic Markets - by Place 9.1 Hospital Lab 9.2 Outpatient Lab 9.3 POC For more information about this report visit https://www.researchandmarkets.com/r/2yxre Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Kargil (Ladakh) [India], January 25 (ANI): To mark the occasion of National Tourism Day, Union Minister of State (Independent Charge) for Culture and Tourism Prahlad Singh Patel announced a branch of the Indian Institute of Skiing and Mountaineering (IISM) in Kargil.
Party says he does not have symptoms but came into close contact with someone who tested positive for Covid.
Here’s the moment Therese Coffey disconnects her camera from GMB interview. Credit: Good Morning Britain / ITV
Yahoo Finance